HomeInsights52 Week Low Stocks

Natco Pharma Ltd 52 Week Low

Natco Pharma Ltd 52 Week Low

stocks purchased

₹ 2.0 Cr

Volume Transacted

(Jan 15, 2025)

stocks purchased

16.6 K

Stocks Traded

(Jan 15, 2025)

Last Updated on: Jan 15, 2025

Image

Natco Pharma Ltd

NSE: NATCOPHARM

YEARLOW

₹ 804.7

Last updated on: Jan 15, 2025

Key Highlights

  • The 52 Week Low of Natco Pharma Ltd is ₹ 804.7 as of 15 Jan 25 .

Company Fundamentals for Natco Pharma Ltd

No data available

Market Price of Natco Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251220.6
14 Jan 20251255.8
13 Jan 20251212.35
10 Jan 20251235.5
09 Jan 20251288.95
08 Jan 20251318.7
07 Jan 20251326.6
06 Jan 20251310.15
03 Jan 20251366.85
02 Jan 20251385.35

Asset Value vs Market Value of Natco Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Natco Pharma Ltd News Hub

News

Natco Pharma Ltd gains for third straight session

Natco Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 1479...

Read more

19 Dec 2024 13:05

News

Natco Pharma Ltd soars 1.05%, Gains for third straight session

Natco Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 1...

Read more

03 Dec 2024 13:06

News

Natco Pharma sells Telangana land for Rs 116 crore

The drug maker stated that since no business operations are carried out on the said land a...

Read more

28 Nov 2024 11:31

News

Natco Pharma submits ANDA with USFDA for Risdiplam for Oral solution

Natco Pharma today announced submission of Abbreviated New Drug Application (ANDA) with US...

Read more

21 Nov 2024 17:35

News

Natco Pharma submits ANDA with US FDA for Risdiplam

The ANDA is a generic version of Evrysdi (Risdiplam) for oral solution by Genentech Inc. R...

Read more

21 Nov 2024 15:00

News

Natco Pharma Ltd eases for fifth straight session

Natco Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 13...

Read more

13 Nov 2024 13:14

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Natco Pharma Ltd

Why is it important to track the 52-week low of Natco Pharma Ltd stocks?

Investors should monitor the 52-week low of Natco Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Natco Pharma Ltd stocks hitting a 52-week low?

Factors leading to Natco Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Natco Pharma Ltd stocks when they hit a 52-week low?

Buying Natco Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Natco Pharma Ltd stocks?

Investors should monitor the 52-week low of Natco Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Natco Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Natco Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Natco Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Natco Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Natco Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions